Fmoc-Arg(Pbf)-OPfp

Fmoc-Arg(Pbf)-OPfp is an Fmoc-protected arginine derivative bearing a Pbf-protected guanidinium side chain and an OPfp ester (pentafluorophenyl ester) at the carboxylate position, giving a chiral amino acid building block with orthogonal functional-group reactivity. The molecule contains an N-(9-fluorenylmethoxycarbonyl) carbamate that supports standard base-stable peptide coupling workflows, while the Pbf (2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl) group masks the strongly basic guanidinium functionality to suppress side reactions during chain assembly. The OPfp ester activates the carboxylate for acyl transfer under peptide-synthesis conditions, enabling efficient formation of amide bonds while maintaining compatibility with orthogonal deprotection strategies. The combination of a protected stereocenter, protected side-chain nucleophile, and activated ester functionality makes the compound well suited as a protected amino acid intermediate and peptide coupling reagent precursor in both research and manufacturing contexts.

1. Peptide Synthesis

Fmoc-Arg(Pbf)-OPfp is applied in peptide synthesis as an activated, protected arginine building block that couples through the OPfp ester to form peptide amide linkages. The Fmoc carbamate on the alpha-amino group enables stepwise N-terminal deprotection and iterative chain growth, while the Pbf-protected guanidinium side chain preserves arginine's chemoselectivity by preventing uncontrolled nucleophilic participation during coupling. The orthogonality between Fmoc removal and Pbf stability supports controlled generation of arginine-containing sequences, including peptides where guanidinium must remain masked until the final deprotection stage. Downstream, the activated ester functionality supports preparation of arginine-rich peptides and peptide fragments used in biochemical research and synthetic methodology development.

2. Protected Amino Acid Chemistry

Fmoc-Arg(Pbf)-OPfp serves in protected amino acid chemistry as a carboxyl-activated intermediate designed for amino acid derivatization and protected amino acid synthesis workflows. The OPfp ester provides a leaving-group-enabled pathway for acylation, allowing conversion into peptide-ready or further derivatized carboxamide products while retaining the Fmoc-protected nitrogen and Pbf-protected side chain. The stereodefined arginine backbone supports incorporation of the correct configuration into peptide building blocks, which is crucial for maintaining stereochemical fidelity in downstream peptide analogs. Orthogonal protection of both the alpha-amino and guanidinium groups also supports sequential deprotection strategies that can be aligned with manufacturing-scale peptide assembly logic.

3. Peptidomimetics And SAR Studies

Fmoc-Arg(Pbf)-OPfp is utilized in peptidomimetic construction and structure-activity relationship (SAR) studies where arginine-like guanidinium interactions must be introduced with controlled protection and activation. The protected guanidinium (Pbf) enables late-stage unmasking to generate a cationic side chain that can participate in binding-site electrostatics after peptide or peptidomimetic assembly. The OPfp ester supports rapid formation of amide-linked scaffolds that can be diversified into analog series, including modifications at the backbone connectivity while keeping the side-chain functionality masked until required. The Fmoc handle further supports standardized fragment coupling routes, enabling consistent generation of arginine-containing analogs for SAR mapping and chemical biology probe development.

4. Chemical Manufacturing Intermediates

Fmoc-Arg(Pbf)-OPfp is relevant to pharmaceutical intermediate preparation and fine chemical synthesis as a manufacturing-compatible arginine derivative that integrates protecting-group strategy with activated-carboxyl functionality. The OPfp ester can be employed to streamline conversion of protected arginine into peptide-coupling-ready intermediates within process chemistry routes that prioritize controllable chemoselectivity and minimized side reactions. The Fmoc and Pbf groups provide orthogonal protection points that can be aligned with stepwise processing, including staged deprotection to expose the guanidinium functionality only when required for final product formation. The resulting intermediate utility supports scalable production of arginine-containing peptide intermediates and related functional molecules used in applied peptide science supply chains.

5. Bioconjugation Building Blocks

Fmoc-Arg(Pbf)-OPfp can be applied to bioconjugation chemistry and biomolecule modification where arginine-containing linkers or peptide handles are required for controlled attachment. The compound's protected guanidinium side chain allows incorporation of a cationic motif into linker peptides without premature interaction with nucleophilic sites during synthesis, while the activated OPfp ester supports formation of amide bonds to generate conjugation-ready constructs. The Fmoc-protected alpha-amino group supports standardized assembly of defined N-terminal segments that can later be deprotected to enable site-specific coupling to biomolecule-reactive partners. Downstream, the resulting arginine-bearing conjugation scaffolds can be used to build chemical biology tools, affinity ligands, or labeling reagents that rely on guanidinium-mediated recognition and stable amide connectivity.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency